These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 25932808)

  • 21. Comparing the alpha-galactosidase A biochemical properties from healthy individuals and Fabry disease patients.
    Daitx VV; Mezzalira J; Moraes Vda C; Breier AC; Cé J; Coelho JC
    Clin Chim Acta; 2015 May; 445():60-4. PubMed ID: 25804996
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Cardiological follow-up in patients with Fabry disease].
    Pieruzzi F; Pieroni M; Chimenti C; Frustaci A; Sarais C; Cecchi F;
    G Ital Cardiol (Rome); 2010; 11(7-8):566-72. PubMed ID: 21033333
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chronic kidney disease and an uncertain diagnosis of Fabry disease: approach to a correct diagnosis.
    van der Tol L; Svarstad E; Ortiz A; Tøndel C; Oliveira JP; Vogt L; Waldek S; Hughes DA; Lachmann RH; Terryn W; Hollak CE; Florquin S; van den Bergh Weerman MA; Wanner C; West ML; Biegstraaten M; Linthorst GE
    Mol Genet Metab; 2015 Feb; 114(2):242-7. PubMed ID: 25187469
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical and genetic analysis of Fabry disease: report of six cases including three heterozygous females.
    Nagasaki A; Nishie W; Sato K; Oba I; Noguchi E; Akitsu H; Sawamura D; Shimizu H
    J Dermatol Sci; 2008 Oct; 52(1):61-4. PubMed ID: 18555667
    [No Abstract]   [Full Text] [Related]  

  • 25. [4th international symposium on hereditary storage diseases].
    Launay D
    Rev Med Interne; 2005 Feb; 26(2):171-3. PubMed ID: 15770790
    [No Abstract]   [Full Text] [Related]  

  • 26. Anderson-Fabry disease: a case-finding study among male kidney transplant recipients in Austria.
    Kleinert J; Kotanko P; Spada M; Pagliardini S; Paschke E; Paul K; Voigtländer T; Wallner M; Kramar R; Stummvoll HK; Schwarz C; Horn S; Holzer H; Födinger M; Sunder-Plassmann G
    Transpl Int; 2009 Mar; 22(3):287-92. PubMed ID: 18954370
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fabry disease in patients with hypertrophic cardiomyopathy (HCM).
    Beer G; Reinecke P; Gabbert HE; Hort W; Kuhn H
    Z Kardiol; 2002 Dec; 91(12):992-1002. PubMed ID: 12490989
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fabry disease presenting as apical left ventricular hypertrophy in a patient carrying the missense mutation R118C.
    Caetano F; Botelho A; Mota P; Silva J; Leitão Marques A
    Rev Port Cardiol; 2014 Mar; 33(3):183.e1-5. PubMed ID: 24661928
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fabry disease: identification of novel alpha-galactosidase A mutations and molecular carrier detection by use of fluorescent chemical cleavage of mismatches.
    Germain DP; Poenaru L
    Biochem Biophys Res Commun; 1999 Apr; 257(3):708-13. PubMed ID: 10208848
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel alpha-galactosidase A mutation in a female with recurrent strokes.
    Tuttolomondo A; Duro G; Miceli S; Di Raimondo D; Pecoraro R; Serio A; Albeggiani G; Nuzzo D; Iemolo F; Pizzo F; Sciarrino S; Licata G; Pinto A
    Clin Biochem; 2012 Nov; 45(16-17):1525-30. PubMed ID: 22820434
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of enzyme replacement therapy on the cardiomyopathy of Anderson-Fabry disease: a randomised, double-blind, placebo-controlled clinical trial of agalsidase alfa.
    Hughes DA; Elliott PM; Shah J; Zuckerman J; Coghlan G; Brookes J; Mehta AB
    Heart; 2008 Feb; 94(2):153-8. PubMed ID: 17483124
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison between alpha-galactosidase A activity in blood samples collected on filter paper, leukocytes and plasma.
    Daitx VV; Mezzalira J; Goldim MP; Coelho JC
    Clin Biochem; 2012 Oct; 45(15):1233-8. PubMed ID: 22569598
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An atypical variant of Fabry's disease in men with left ventricular hypertrophy.
    Nakao S; Takenaka T; Maeda M; Kodama C; Tanaka A; Tahara M; Yoshida A; Kuriyama M; Hayashibe H; Sakuraba H
    N Engl J Med; 1995 Aug; 333(5):288-93. PubMed ID: 7596372
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Fabry disease: clinic and enzymatic diagnosis of homozygous and heterozygous. New therapeutic prospects].
    Peces R; Olea T
    Nefrologia; 2002; 22(6):540-6. PubMed ID: 12516287
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Angiokeratomas - When is a few too many?
    O'Mahony C; Franks A; Llewellyn R
    Int J STD AIDS; 2014 Apr; 25(5):378-9. PubMed ID: 24104692
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Heterozygote detection in Fabry disease utilizing multiple enzyme activities.
    Sheth KJ; Good TA; Murphy JV
    Am J Med Genet; 1981; 10(2):141-6. PubMed ID: 6274191
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fabry disease in childhood.
    Desnick RJ; Brady RO
    J Pediatr; 2004 May; 144(5 Suppl):S20-6. PubMed ID: 15126980
    [No Abstract]   [Full Text] [Related]  

  • 38. Acute Decompensated Heart Failure After Initiation of Amiodarone in a Patient With Anderson-Fabry Disease.
    Fine NM; Wang Y; Khan A
    Can J Cardiol; 2019 Jan; 35(1):104.e5-104.e7. PubMed ID: 30595173
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Diffuse Fabry's angiokeratoma].
    Trofimova IB; Aĭvazian AA
    Vestn Dermatol Venerol; 1983 Jan; (1):54-7. PubMed ID: 6299021
    [No Abstract]   [Full Text] [Related]  

  • 40. Comparison of two tests for serum alpha-galactosidase in nonneuromuscular left ventricular hypertrabeculation/concompaction.
    Finsterer J; Stöllberger C; Voigtländer T
    Jpn Heart J; 2004 Jan; 45(1):179-81. PubMed ID: 14973364
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.